Novo Nordisk faces setbacks with semaglutide in Alzheimer's trials and declining growth. Read here for analyst outlook and ...

A build-up of sticky proteins in the brain is a key hallmark of Alzheimer's, thought to be closely linked to the disease's ...

Major stock indexes ended sharply higher Monday to begin a holiday-shortened trading week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Chris Hemsworth 's equally heartbreaking and heartwarming new documentary about his dad's dementia, "A Road Trip to Remember, ...

For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood ...

Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus wasn’t better than a placebo at delaying the progression of Alzheimer’s disease. It shared few details beyond saying the ...

C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...

The lab, led by Carleara Weiss, explores the relationship between Alzheimer’s disease and biomarkers of neurodegeneration, ...

Molecular profiles of oligodendrocytes and microglia in rhesus monkeys that followed a lifelong 30% calorie restriction diet ...

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...

New data raise the question of whether statins increase cardiovascular or cerebrovascular hospitalizations in dementia, but ...

New research shows that young adults with obesity already display biological patterns associated with liver stress, chronic inflammation, and early neural injury—changes typically seen in older adults ...